Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cat pelt extract is a standardized allergenic extract used for the diagnosis and treatment (immunotherapy) of patients with cat allergies. [5, 10] The extract is prepared from defatted and dried cat pelts, which consist of hair and the entire epidermis. It is a biologic product whose primary active ingredient is the Fel d 1 allergen, though it also contains other non-Fel d 1 allergens like cat serum albumin. [3] The extract's potency is standardized by quantifying its Fel d 1 content against FDA reference standards, and it is labeled in Bioequivalent Allergy Units (BAU/mL). [5] Administration is through percutaneous testing for diagnosis, intradermal testing for diagnosis, or subcutaneous injection for immunotherapy, with the goal of inducing hyposensitization in patients. [10] It is not interchangeable with standardized cat hair extract, which has a different allergen profile. [3, 5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cat pelt extract.